Home » Stocks » NSPX

Inspyr Therapeutics, Inc. (NSPX)

Stock Price: $0.0065 USD -0.0003 (-4.41%)
Updated Jul 22, 2021 3:59 PM EDT - Market closed
Market Cap 3.42M
Revenue (ttm) n/a
Net Income (ttm) -26.27M
Shares Out 424.95M
EPS (ttm) -0.18
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 22
Last Price $0.0065
Previous Close $0.0068
Change ($) -0.0003
Change (%) -4.41%
Day's Open 0.0069
Day's Range 0.0062 - 0.0069
Day's Volume 1,064,610
52-Week Range 0.0005 - 0.0718

News

Proceeds support the development of lead asset, RT-AR001, an adenosine receptor antagonist Funds were secured from an existing institutional investor WESTLAKE VILLAGE, CA / ACCESSWIRE / January 12, 2021...

6 months ago - Accesswire

About NSPX

Inspyr Therapeutics, Inc., a pharmaceutical company, focuses on the research and development of therapeutics for the treatment of cancer. Its immune-oncology lead asset is RT-AR001, an adenosine A2B receptor antagonist for tumor infiltration. The company was formerly known as GenSpera Inc. and changed its name to Inspyr Therapeutics, Inc. in August 2016. Inspyr Therapeutics, Inc. was incorporated in 2003 and is based in Westlake Village, California.

Industry
Biotechnology
Founded
2003
Stock Exchange
OTCMKTS
Ticker Symbol
NSPX
Full Company Profile

Financial Performance

Financial Statements